Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

WebMD Appoints Blake DeSimone as Chief Financial Officer

WebMD Health Corp.
Posted on: 27 Sep 16

PR Newswire

NEW YORK, Sept. 27, 2016

NEW YORK, Sept. 27, 2016 /PRNewswire/ -- WebMD Health Corp. (NASDAQ WBMD), the leading source of health information, today announced that the Board of Directors has appointed Blake DeSimone, its Senior Vice President of Finance, as its Chief Financial Officer.  Mr. DeSimone succeeds Peter Anevski who is leaving the Company.

Mr. DeSimone, 40, joined WebMD as its Senior Vice President of Finance in June 2015.  In that role, he has been responsible for the Company's SEC and financial reporting, financial planning and analysis, and treasury management. Prior to joining WebMD, Mr. DeSimone was Chief Financial Officer of D+M Holdings, a global consumer electronics company that had approximately $500 million of annual revenue during his tenure.  Prior to that, he was President and CFO of Advogent Group, Inc., a services company providing sales and marketing support to the healthcare industry.  He also served in other executive roles at Cardinal Health and Boron Lepore & Associates, Inc.  Mr. DeSimone is a Certified Public Accountant and started his career in Arthur Andersen's Assurance Practice.

Steven L. Zatz, M.D., Chief Executive Officer of WebMD, said "I congratulate Blake on his promotion. Over the past year, I have had the opportunity to work closely with Blake, who has been a strong leader in our finance organization. Blake provides a unique combination of financial, operational and healthcare experience that will be of great value to the Company in his new role."  Dr. Zatz added, "We thank Pete for his many contributions during his tenure with the Company and wish him well in his future endeavors."

"I am excited to have this opportunity to become WebMD's Chief Financial Officer," said Mr. DeSimone. "We have a strong finance organization and I expect my transition to be seamless. I look forward to working closely with Steve to drive the future growth of WebMD."

WebMD also announced today that it expects its financial results for the third quarter and full year of 2016 to be around the high end of its financial guidance issued on August 8, 2016. That financial guidance and this reaffirmation do not reflect the impact of deployment of capital for items such as share repurchases, convertible note repurchases or acquisitions, gains or losses from discontinued operations, or other non-recurring, one-time or unusual items in the quarters for which guidance was provided, including stock repurchases and severance related to recent management changes in the third quarter of 2016.

As previously announced, WebMD will hold its Annual Meeting of Stockholders on September 29, 2016, beginning at 9:30 a.m. (ET), at W New York – Union Square, 201 Park Avenue South, New York, New York. Investors can access a live audio webcast of the meeting at www.wbmd.com (in the Investor Relations section). A replay of the webcast will be available at the same web address.

About WebMD

WebMD Health Corp. (NASDAQ: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers, and health plans through our public and private online portals, mobile platforms and health-focused publications.

The WebMD Health Network includes WebMD.com, Medscape.com, MedicineNet.com, eMedicineHealth.com, RxList.com, Medscape Education (Medscape.org) and other WebMD owned sites and apps.

All statements contained in this press release, other than statements of historical fact, are forward-looking statements, including those regarding:  guidance on our future financial results; and market opportunities and our ability to capitalize on them. These statements speak only as of the date of this press release, are based on our current plans and expectations, and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to: market acceptance of our products and services; our relationships with customers and other factors affecting their use of our services and the timing of entry into and implementation of specific contracts with customers, including regulatory matters affecting their products and services; our ability to deploy new or updated services and to create new or enhanced revenue streams from those services; our ability to attract and retain qualified personnel; and changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet and information technology industries.  Further information about these matters can be found in our Securities and Exchange Commission filings and this press release is intended to be read in conjunction with information contained in those filings. Except as required by applicable law or regulation, we do not undertake any obligation to update our forward-looking statements to reflect future events or circumstances.

WebMD®, Medscape®, CME Circle®, Medpulse®, eMedicine®, MedicineNet®, theheart.org® and RxList® are among the trademarks of WebMD Health Corp. or its subsidiaries.

Logo - http://photos.prnewswire.com/prnh/20150811/257757LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/webmd-appoints-blake-desimone-as-chief-financial-officer-300334687.html

SOURCE WebMD Health Corp.

PR Newswire
www.prnewswire.com

Last updated on: 27/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.